Who owns LANTERN PHARMA INC?
- Ticker: LTRN
- CUSIP Number: 51654w101
Tip: Access positions for across all investors
Analyze quarterly positions in Lantern Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lantern Pharma stock
Who bought or sold LANTERN PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BIOS Capital Management | 1.0M | $4.4M | -6% | Sep 2025 |
|
| Vanguard Group | 384k | $1.7M | 6% | Sep 2025 |
|
| CM Management | 225k | $979k | 12% | Sep 2025 |
|
| Renaissance Technologies | 100k | $435k | 10% | Sep 2025 |
|
| Geode Capital Management | 92k | $401k | 0% | Sep 2025 |
|
| Voss Capital | 50k | $218k | 0% | Sep 2025 |
|
| Goss Wealth Management | 47k | $206k | -16% | Sep 2025 |
|
| BlackRock | 43k | $187k | 2% | Sep 2025 |
|
| Dimensional Fund Advisors | 40k | $175k | -2% | Sep 2025 |
|
| Susquehanna International | 39k | $170k | 100% | Sep 2025 |
|
| Westside Investment Management | 36k | $156k | 0% | Sep 2025 |
|
| UBS Group | 33k | $144k | 34% | Sep 2025 |
|
| Horizon Kinetics Asset Management | 29k | $125k | 4% | Sep 2025 |
|
| Bank of New York Mellon | 27k | $115k | 0% | Sep 2025 |
|
| Davenport & Co | 26k | $112k | 0% | Sep 2025 |
|
| State Street Corporation | 24k | $103k | 0% | Sep 2025 |
|
| Citadel Advisors | 18k | $80k | 12% | Sep 2025 |
|
| Commonwealth Equity Services | 18k | $79k | 0% | Sep 2025 |
|
| Two Sigma Investments | 16k | $70k | 100% | Sep 2025 |
|
| Northern Trust | 16k | $68k | 0% | Sep 2025 |
|
| Group One Trading | 5.1k | $22k | 71% | Sep 2025 |
|
| SBI Securities | 2.1k | $9.3k | -1% | Sep 2025 |
|
| Hanson McClain Advisors | 2.1k | $9.1k | 2000% | Sep 2025 |
|
| Wells Fargo & Company | 1.7k | $7.5k | -65% | Sep 2025 |
|
| Simplex Trading | 1.4k | $6.0k | 100% | Sep 2025 |
|
| Morgan Stanley | 601.00 | $1.8k | 100% | Jun 2025 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $2.2k | 0% | Sep 2025 |
|
| Tower Research Capital | 430.00 | $1.9k | -63% | Sep 2025 |
|
| Advisor Group Holdings | 215.00 | $934.992000 | 0% | Sep 2025 |
|
| Key FInancial | 2.00 | $8.000000 | 0% | Sep 2025 |
|
Who sold out of Lantern Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 13k | $40k |
| Raymond James Financial | Jun 2025 | 2.7k | $8.6k |
| Curio Wealth | Jun 2025 | 2.0k | $6.3k |
| Federation des caisses Desjardins du Quebec | Jun 2025 | 800.00 | $2.5k |
| Parkside Financial Bank & Trust | Jun 2025 | 260.00 | $821.990000 |
| Newbridge Financial Services Group | Jun 2025 | 200.00 | $632.000000 |
| Jpmorgan Chase & Co | Mar 2025 | 128.00 | $453.004800 |
| FMR | Jun 2025 | 74.00 | $234.002800 |